- The sale resulted in aggregate gross proceeds of c. CHF 1.3 billion, of which EQT received c. CHF 354 million
STOCKHOLM, March 13, 2025 /PRNewswire/ -- Further to previous announcements, an affiliate of the funds known as EQT VIII ("EQT") is pleased to announce the completion of the placement of 15,000,000 shares in Galderma Group AG (SIX: GALD) (the "Company") (the "Shares") for aggregate gross proceeds of c. CHF 1.3 billion via an accelerated bookbuilding process (the "Placement").
As part of the Placement, EQT received gross proceeds of c. CHF 354 million. The Placement was completed on 13 March 2025. BNP Paribas, BofA Securities, Goldman Sachs, Morgan Stanley and UBS acted as joint global coordinators and joint bookrunners for the Placement.
Contact
EQT Press Office, press@eqtpartners.com
Important notice
This press release does not constitute (i) an offer to sell or a solicitation of an offer to buy any securities of Galderma Group AG or any of its affiliates and it does not constitute a prospectus within the meaning of the Swiss Financial Services Act or (ii) an offer of securities for sale in the United States or elsewhere. Securities may not be offered or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration. There will be no public offering of any of the securities mentioned in this press release in the United States
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4118650
The following files are available for download:
https://mb.cision.com/Main/87/4118650/3320455.pdf | PR_EQT completes sale of shares in Galderma_13.03.25 |
View original content:https://www.prnewswire.co.uk/news-releases/eqt-completes-sale-of-shares-in-galderma-group-ag-302401356.html
